Showing results (611-620 of 4,622) with videos related to
Sort By:
Pageof 463
Journal of Neuroinflammation|August 5, 2015
Prolonged diet-induced obesity in mice modifies the inflammatory response and leads to worse outcome after strokeSamaneh Maysami, Michael J Haley, Natalia Gorenkova, et al.Journal of Neuroinflammation|October 16, 2015
Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microgliaChao Huang, Xu Lu, Lijuan Tong, et al.Journal of Neuroinflammation|October 14, 2015
Expression pattern of Ccr2 and Cx3cr1 in inherited retinal degenerationHideo Kohno, Hideto Koso, Kiichiro Okano, et al.Journal of Neuroinflammation|July 13, 2016
Transcriptome sequencing reveals that LPS-triggered transcriptional responses in established microglia BV2 cell lines are poorly representative of primary microgliaAmitabh Das, Sun Hwa Kim, Sarder Arifuzzaman, et al.Journal of Neuroinflammation|July 13, 2016
Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase ARamy Habashy Malty, Andy Hudmon, Jill C Fehrenbacher, et al.Journal of Neuroinflammation|July 26, 2017
Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injuryRaffaela Cipriani, Juan Carlos Chara, Alfredo Rodríguez-Antigüedad, et al.Journal of Neuroinflammation|August 5, 2017
microRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cellsReema Roshan, Ashwani Choudhary, Aksheev Bhambri, et al.Journal of Neuroinflammation|June 9, 2016
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itselfSaskia Maria Burm, Laura Anna Norma Peferoen, Ella Alwine Zuiderwijk-Sick, et al.Journal of Neuroinflammation|June 26, 2016
A critical time window for the analgesic effect of central histamine in the partial sciatic ligation model of neuropathic painJie Yu, Ying-Ying Tang, Ran-Ran Wang, et al.Journal of Neuroinflammation|June 29, 2016
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studiesT Sehr, U Proschmann, K Thomas, et al.Pageof 463